Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone

Hun Kang, Jung; Il Lee, Soon; Hyoung Lim, Do; Woo Park, Keon; Yong Oh, Sung; Kwon, Hyuk‐Chan; Gyu Hwang, In; Lee, Sang‐Cheol; Nam, Eunmi; Bok Shin, Dong; Lee, Jeeyun; Oh Park, Joon; Suk Park, Young; Yeong Lim, Ho; Ki Kang, Won; Hoon Park, Se

doi:10.1200/jco.2011.39.4585

Public

Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone

Published in Journal of Clinical Oncology • Mar 13, 2012

Authors:

Jung Hun Kang

Soon Il Lee

Do Hyoung Lim

Abstract

PURPOSE: When designing this trial, there was no evidence that salvage chemotherapy (SLC) in advanced gastric cancer (AGC) resulted in substantial prolongation of survival when compared with best supportive care (BSC). However, SLC is often offered to pretreated patients with AGC for anecdotal reaso...

Subject

Medicine

Docetaxel

Irinotecan

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!